Technical Analysis for GBT - Global Blood Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 84.75 -1.09% -0.93
GBT closed up 1.77 percent on Thursday, January 16, 2020, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical GBT trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish -2.81%
Pocket Pivot Bullish Swing Setup -2.81%
Slingshot Bullish Bullish Swing Setup -2.81%
Doji - Bearish? Reversal -2.81%
New 52 Week High Strength -2.81%
Stochastic Reached Overbought Strength -2.81%
Upper Bollinger Band Walk Strength -2.81%
Outside Day Range Expansion -2.81%
Above Upper BB Strength -2.81%
Overbought Stochastic Strength -2.81%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
Medicine Biopharmaceutical Medical Specialties Blood Hereditary Angioedema Sickle Cell Disease Angioedema Hemoglobin Hemoglobins

Is GBT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 87.5
52 Week Low 43.69
Average Volume 1,302,287
200-Day Moving Average 57.72
50-Day Moving Average 69.79
20-Day Moving Average 80.61
10-Day Moving Average 82.45
Average True Range 3.43
ADX 29.8
+DI 27.24
-DI 20.49
Chandelier Exit (Long, 3 ATRs ) 77.20
Chandelier Exit (Short, 3 ATRs ) 81.90
Upper Bollinger Band 86.73
Lower Bollinger Band 74.50
Percent B (%b) 1.04
BandWidth 15.18
MACD Line 3.90
MACD Signal Line 3.95
MACD Histogram -0.0447
Fundamentals Value
Market Cap 3.81 Billion
Num Shares 43.7 Million
EPS -2.46
Price-to-Earnings (P/E) Ratio -35.45
Price-to-Sales 0.00
Price-to-Book 5.19
PEG Ratio -0.38
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 94.69
Resistance 3 (R3) 93.95 90.73 93.44
Resistance 2 (R2) 90.73 88.82 91.09 93.02
Resistance 1 (R1) 88.96 87.64 89.85 89.70 92.61
Pivot Point 85.74 85.74 86.18 86.10 85.74
Support 1 (S1) 83.97 83.83 84.86 84.71 81.79
Support 2 (S2) 80.75 82.65 81.11 81.38
Support 3 (S3) 78.98 80.75 80.96
Support 4 (S4) 79.72